-
Selecting right capsule for a pharma product
Muhammad Asim Niazi
April 11, 2023
Capsules are enclosed shells mainly made up of gelling agents that can provide suitable human conditions inside a human stomach. They enclose a pharma product without any additional mechanism, material or manufacturing process.
-
Tyme and Eagle Pharmaceuticals partner for cancer candidate oral
pharmaceutical-technology
January 09, 2020
Tyme Technologies has entered a strategic collaboration with Eagle Pharmaceuticals for cancer metabolism-based therapy (CMBT) candidate oral SM-88.
-
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
b3cnewswire
October 31, 2019
SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors.
-
Oral Health Symptoms in Seniors Associated With Cognitive Decline
drugs
September 27, 2019
Among U.S. Chinese older adults, oral (teeth and gums) health symptoms are associated with a decline in cognitive function, according to a study published online in the Journal of the American Geriatrics Society.
-
Herd Protection Against Oral HPV Infections Seen Among Men
drugs
September 12, 2019
In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016...
-
Oral Antibiotic Use Linked to Risk for Colorectal Cancer
drugs
August 22, 2019
Oral antibiotic use is associated with an increased risk for colon cancer and a reduced risk for rectal cancer, according to a study published online in Gut.
-
Minority, Low-Income Individuals Less Likely to Receive Oral Cancer Screening
drugs
August 21, 2019
Despite a recent dental visit, more individuals of a minority race/ethnicity and low socioeconomic status report not receiving an oral cancer screening exam...
-
Mechanical, Oral Antibiotic Bowel Prep Yields No Benefit for Colectomy
drugs
August 20, 2019
Mechanical and oral antibiotic bowel preparation (MOABP) does not reduce surgical site infections (SSIs) or the overall morbidity of colon surgery versus no bowel preparation (NBP)...
-
FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis
drugs
August 19, 2019
AbbVie, a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor...
-
Sleep Apnea Traits May Predict Response to Oral Appliance Tx
drugs
August 12, 2019
Quantifying obstructive sleep apnea (OSA) traits using clinical polysomnography may identify an endotype-based subgroup of patients that is responsive to oral appliance therapy...